Article
Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.
Antimicrobial agents and chemotherapy - 1 Dec 2002
Wang Michael Z, Tai Chun Y, Mendel Dirk B
Abstract excerpt
Oseltamivir carboxylate is a potent and specific inhibitor of influenza neuraminidase (NA). An influenza A/H1N1 variant selected in vitro with reduced susceptibility to oseltamivir carboxylate contains a His274Tyr mutation. To understand the mechanism by which a His274Tyr mutation gives rise to drug resistance, we studied a series of NA variant proteins containing various substitutions at position 274....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
